Key result
Left atrial appendage closure is considered an alternative to long-term oral anticoagulation for patients with atrial fibrillation to reduce stroke risk and bleeding burden.
Answers are grounded in this paper and cite their sources.
Highlights the clinical context and rationale for referring patients with atrial fibrillation for left atrial appendage closure, emphasizing factors like bleeding risk and frailty.
Left atrial appendage closure (LAAC) is commonly considered for patients with atrial fibrillation (AF) who seek an alternative to long-term oral anticoagulation (OAC). In practice, referral may follow major bleeding, recurrent falls, complex antithrombotic needs, real or perceived inability to sustain OAC, or patient unwillingness to take it indefinitely. The device’s appeal rests on the possibility of reducing cardioembolic stroke risk while limiting long-term exposure to anticoagulants and their attendant bleeding burden.
No takes yet. Share an insight, caveat, or question.
Amuthan et al. (2026) conducted an editorial in Atrial fibrillation. Left atrial appendage closure (LAAC) vs. Oral anticoagulation (OAC) was evaluated. Left atrial appendage closure is considered an alternative to long-term oral anticoagulation for patients with atrial fibrillation to reduce stroke risk and bleeding burden.
Synapse has enriched 10 related papers. Consider them for comparative context: